Mehmet Haluk Yücel

9PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionModels of care and place of birthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 04, 2026
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.

|May 04, 2026
A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score.

|May 04, 2026
Survival Outcomes After irAE-Related Nivolumab Discontinuation in mNSCLC: A Multicenter Study.

|Mar 28, 2026
Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.

Maral Martin Mildanoglu, Mehmet Haluk Yucel, Ebru Engin Delipoyraz

|Mar 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCR.

Ayberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu

|Mar 17, 2026
Association between malnutrition diagnosed by GLIM criteria and one-year mortality in hospitalized elderly patients: A prospective observational study.

Mehmet Yürüyen, Gizem Geçmez, Havva Nur Doğan Güven

Pageof 2

Frequent Collaborators

7 joint publications

Ahmet Bilici

6 joint publications

Harun Muğlu

5 joint publications

Jamshid Hamdard

5 joint publications

Özgür Açıkgöz